Harvest Portfolios Group’s AstraZeneca AZN Stock Holding History

Harvest Portfolios Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$74.5M	Buy	377,620 +213	+0.1%	+$41.1K	1.23%	21
2025 Q4	$69.4M	Sell	377,407 -19,565	-5%	-$3.43M	1.21%	19
2025 Q3	$60.9M	Sell	396,972 -10,110	-2%	-$1.53M	1.12%	25
2025 Q2	$56.9M	Sell	407,082 -4,899	-1%	-$687K	1.32%	24
2025 Q1	$60.6M	Buy	411,981 +4,942	+1%	+$715K	1.79%	9
2024 Q4	$53.3M	Buy	407,039 +42,945	+12%	+$6.01M	1.78%	11
2024 Q3	$56.7M	Buy	364,094 +10,757	+3%	+$1.74M	1.88%	15
2024 Q2	$55.1M	Sell	353,337 -37,296	-10%	-$5.61M	2.11%	10
2024 Q1	$52.9M	Buy	390,633 +3,260	+0.8%	+$432K	2.07%	15
2023 Q4	$52.2M	Sell	387,373 -9,644	-2%	-$1.25M	2.21%	17
2023 Q3	$53.8M	Buy	397,017 +41,112	+12%	+$5.62M	2.54%	5
2023 Q2	$50.9M	Sell	355,905 -30,489	-8%	-$4.49M	2.34%	12
2023 Q1	$53.6M	Buy	386,394 +27,297	+8%	+$3.67M	2.63%	4
2022 Q4	$48.7M	Buy	+359,097	New	+$45M	2.8%	4

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Harvest Portfolios Group's AZN Position: Q1 2026 in Review

Harvest Portfolios Group increased its AstraZeneca (AZN) stake by 0.06% in Q1 2026, buying an estimated $41.1K and bringing the position to 377,620 shares worth $74.5M. The position accounts for 1.23% of the portfolio, ranked #21.

Harvest Portfolios Group first reported a position in AZN in Q4 2022 and has held it in 14 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Harvest Portfolios Group held 377,620 shares of AstraZeneca worth $74.5M as of Q1 2026.
Harvest Portfolios Group bought 213 AstraZeneca shares in Q1 2026, an estimated $41.1K.
AstraZeneca made up 1.23% of Harvest Portfolios Group's portfolio in Q1 2026, its #21 holding.
Harvest Portfolios Group first reported a position in AstraZeneca in Q4 2022 and has held it in 14 quarters since.
1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Harvest Portfolios Group's 13F filing for Q1 2026, filed 14 May 2026.